Drug intelligence / Profile preview

OnePrep

Development stage
Unknown
Lead developer
Gunkang Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

OnePrep (also known as OnePrep 1.38 or 원프렙 1.38산) is a low-volume bowel-cleansing agent developed by Gunkang Pharmaceuticals and co-marketed with GC Green Cross Wellbeing. Approved in South Korea as an improved generic drug (개량신약), it is indicated for bowel preparation and colon cleansing prior to colonoscopy. OnePrep is a combination formulation consisting of D-sorbitol, ascorbic acid, and sodium picosulfate hydrate. It is designed to significantly reduce the required fluid intake compared to traditional polyethylene glycol (PEG)-based bowel preps, requiring a total volume of only 1.38 liters (including the reconstituted solution and additional water). The combination works through dual mechanisms: D-sorbitol and ascorbic acid act as osmotic laxatives that draw water into the intestinal lumen, while sodium picosulfate is hydrolyzed by colonic bacteria into its active metabolite, which stimulates colonic peristalsis. This synergistic action ensures effective colon cleansing with improved patient compliance and a pleasant lemon flavor.

Brand names
OnePrepOnePrep 1.38OnePrep1.38OnePrep-1.38OnePrep 1.38 PowderOnePrep1.38 PowderOnePrep-1.38 Powder
Other names
ascorbic acid + D-sorbitol + sodium picosulfateascorbic acid + D-sorbitol + sodium picosulfate hydrate원프렙원프렙 1.38원프렙1.38산원프렙일점삼팔산

Beyond the preview

Go deeper on OnePrep.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OnePrep.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call